Canada markets closed

VolitionRx Limited (VNRX)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.6160-0.0012 (-0.19%)
At close: 04:00PM EDT
0.6545 +0.04 (+6.25%)
After hours: 07:56PM EDT

VolitionRx Limited

1489 West Warm Springs Road
Suite 110
Henderson, NV 89014
United States
646 650 1351
https://www.volition.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full Time Employees110

Key Executives

NameTitlePayExercisedYear Born
Dr. Martin Charles Faulkes Ph.D.Executive Chairman239.51kN/A1944
Mr. Cameron Reynolds MBAFounder, CEO, President & Director572.43kN/A1971
Dr. Gaetan Michel Ph.D.Chief Operating Officer518.15kN/A1974
Dr. Salvatore Thomas Butera DVMChief Executive Officer of Volition Veterinary Diagnostics Development LLC477.25kN/A1952
Mr. Terig HughesCFO & Treasurer338.74kN/A1971
Dr. Jacob Vincent Micallef MBA, Ph.D.Chief Scientific Officer571.55kN/A1956
Mr. Nicholas PlummerGroup General CounselN/AN/A1971
Ms. Louise Batchelor DayGroup Chief Marketing & Communications OfficerN/AN/A1972
Mr. Thomas BygottSales & Marketing DirectorN/AN/AN/A
Mr. Gael Forterre M.B.A.Chief Commercial OfficerN/AN/A1982
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening blood test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.

Corporate Governance

VolitionRx Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.